Anticoagulant treatment of COVID-19 as early as possible – Sulodexide and perspectives
| dc.contributor.author | Schulman S | |
| dc.contributor.author | Harenberg J | |
| dc.date.accessioned | 2021-06-15T16:01:33Z | |
| dc.date.available | 2021-06-15T16:01:33Z | |
| dc.date.issued | 2021-04-08 | |
| dc.date.updated | 2021-06-15T16:01:32Z | |
| dc.description.abstract | <jats:p>No Abstract</jats:p> | |
| dc.identifier.doi | https://doi.org/10.1055/a-1477-3569 | |
| dc.identifier.issn | 0340-6245 | |
| dc.identifier.issn | 2567-689X | |
| dc.identifier.uri | http://hdl.handle.net/11375/26596 | |
| dc.publisher | Georg Thieme Verlag KG | |
| dc.title | Anticoagulant treatment of COVID-19 as early as possible – Sulodexide and perspectives | |
| dc.type | Article |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Anticoagulant treatment of COVID-19 as early as possible – Sulodexide and perspectives.pdf
- Size:
- 1.25 MB
- Format:
- Adobe Portable Document Format
- Description:
- Published version